🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don’t miss out on expert insights at the 6th Annual Precision Medicine Symposium in Boston this October! Join us and elevate your practice! Register now: bit.ly/3VRwEqZ Narjust Florez, MD, FASCO Dr. Andre Goy Irene Ghobrial Pashtoon Kasi MD, MS Erica Mayer Bradley McGregor Aparna Raj Parikh

Retrospective study from Natera and Gregory Botta in The Oncologist Association of personalized and tumor-informed ctDNA with patient survival outcomes in #PancreaticCancer academic.oup.com/oncolo/advance… "In multivariate analysis, ctDNA detection at surveillance was found to be

Congratulations to our WCM Englander Institute for Precision Medicine colleague Dr. Pinkal Desai (Pinkal Desai) on her new ACS Journal Cancer paper "Association of #clonalhematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality." #mCAs #CHIP #WGS acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Enhance your knowledge and network with leading professionals in Hollywood, FL this fall at this year's ISGIO! Don’t miss this opportunity to advance your expertise in GI oncology! Register now: bit.ly/4cOUPMy Tanios Bekaii-Saab, MD Eileen M O’Reilly

👏 Join us in congratulating our members who earned the Fellows of ASCO (FASCO) distinction this quarter! We're grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wLvZf

I’m about to discuss this abstract in a talk and I think I’m starting to understand why stage actors do vocal exercises

Abstract titles for #ESMO24 now online! Full NICHE-3 cohort (59 pts with dMMR colon cancer treated with neoadj nivo/rela) will be presented in proferred paper session + more neoadj IO from Imhotep, and wonderful Jenny Seligmann as discussant. Stay tuned for more exciting💥💥💥news!

Plus a mystery LBA in this session…🤩 💥💥💥 Can’t wait #ESMO24

#MondayMotivation

Guardant Shield is now FDA approved as a blood test for CRC screening.

Based on the ECLIPSE trial, U.S. FDA today approved the Guardant SHIELD blood test for #ColorectalCancer. Matthew Herper in STAT statnews.com/2024/07/29/gua… See ECLIPSE data below & why individuals undergoing this assay should clearly understand - this is NOT a test for CRC

The FDA has approved the Shield blood test as a primary screening option for colorectal cancer, providing patients with more choices for screening. Here is our response. 🧵

Congratulations to my longstanding friend and co-Vail AACR/ASCO workshop alumni 🤩 Smitha Krishnamurthi Cleveland Clinic for being elected by her peers as the new NCI CTEP Clinical Research National Cancer Institute #colon Task Force Co-Chair! Well deserved!!!! 👏👏👏 SWOG Cancer Research Network #CancerResearch #cancer

Thank you so much Dr. Cathy Eng ! My dear friend all these years!🙏🏾🙏🏾🙏🏾 So grateful for the opportunity to work with Jonathan Loree and the NCI CTEP Clinical Research Colon Task Force to advance NCTN concepts!

#ISLB24 So happy to have Daniel Cheung, 1st author of the recent NEJM paper on liquid biopsy in the screening of colorectal cancer, as keynote speaker at our annual ISLB Congress. If you are working in the liquid biopsy space, participation in ISLB24 is a must do. See you there!

I am eager to share that I received my ECFMG certification a few days ago. It’s unreal how years of hard work, countless exams, sleepless nights, my family’s unwavering support (and admittedly lots of tears) has finally culminated into a single piece of paper! 🙌🏽 #Match2025

📢Calling all oncology researchers! We’re accepting submissions for JCO Oncology Advances #JCO #OncologyResearch #OpenAccess Share impactful cancer research with a global community and contribute to advancing clinical oncology. Submit your work: ascopubs.org/journal/oa

Proud to be an Associate Editor alongside Yanin Chávarri A. Dimitrios Colevas MD Maryam Lustberg MD, MPH, FASCO Cathy Handy Marshall, MD MPH Mark Lewis, MD, FASCO Jordi Remon Fidel Rubagumya , MD, MMed, MPH with Pamela Kunz, MD, FASCO at the helm

Hannah 💜 Mridula George #TumorBoardTuesday Maryam Lustberg MD, MPH, FASCO Paolo Tarantino Rebecca Shatsky, MD Erika Hamilton, MD Charu Aggarwal, MD, MPH, FASCO Aditya Bardia, MD Hope Rugo Eleonora Teplinsky, MD Stephanie Graff, MD, FACP, FASCO Jane Lowe Meisel, MD Laura Huppert, MD #TumorBoardTuesday 👌I agree - I am using liquid biopsies🩸more and more ✅Just have to pick the right scenarios to draw the blood ➡️Untreated advanced disease OR ➡️Disease progression 🚫But NOT after treatment has started Correct Pashtoon Kasi MD, MS ❓

Dear Colleagues, The OncoAlert 🚨Network Presents OUR Picks of TOP 🔟 GI Abstracts to be Presented at #ESMO24 This List Curated by: #OncoAlertAF Leads Dr Joseph McCollom DO 🇺🇸 Erman Akkus 🇹🇷 Gil Morgan, MD 🇺🇸 1141O - Cabozantinib versus placebo for advanced neuroendocrine tumors